Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

Keywords

Osteoprotegerin, Osteoclast, Bone remodeling, Inflammation, Arthritis

References

• Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.Anthony Stellon, Andrew Davies, J.E. Compston — 1985
• TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.Régis Josien, Brian Wong, Hongli Li — 1999
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisYoung‐Yun Kong, Hiroki Yoshida, Ildiko Sarosi — 1999
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionDirk Anderson, Eugene Maraskovsky, William L. Billingsley — 1997
• Molecular biology of cartilage and bone destruction.Ulf M ller-Ladner, Renate E. Gay, Steffen Gay — 1998
• Clinical course and prognostic factors following bone recurrence from breast cancer.Robert E. Coleman, Paul Smith, R.D. Rubens — 1998
• Bone Mineral Density and Bone Metabolism in Diabetes MellitusB. Piepkorn, Peter Herbert Kann, Thomas Först — 1997
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.W. Scott Simonet, Dave Lacey, Colin R. Dunstan — 1997
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Paul Waterhouse, Josef Penninger, Emma Timms — 1995
• Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursorsJudy Faust, Dave L. Lacey, Pamela S. Hunt — 1999
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.David L. Lacey, Emma Timms, Hong‐Lin Tan — 1998
• Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.Alison M. Bendele, Tracy McAbee, Gina Sennello — 1999
• TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival FactorBrian Wong, Régis Josien, Soo Young Lee — 1997
• Recent developments in the understanding of the pathophysiology of osteopetrosis.R. Felix, Willy Hofstetter, Marco Cecchini — 1996
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.Hailing Hsu, David L. Lacey, Colin R. Dunstan — 1999
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.Shigeru Kotake, Nobuyuki Udagawa, Naoyuki Takahashi — 1999
• Paget's disease and osteoclast biology.G. David Roodman — 1996
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*Brian Wong, Jaerang Rho, Joseph R. Arron — 1997
• RAG-1-deficient mice have no mature B and T lymphocytes.Peter Mombaerts, John Iacomini, Randall S. Johnson — 1992
• Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitorJames G. Conway, Jean A. Wakefield, Roger H. Brown — 1995

Cited by

• The role of T cells in osteoporosis, an update.Wen Zhao, Yuying Liu, Catherine M. Cahill — 2009
• Have the new drugs relieved the burden of the orthopedic surgeon?Ilham Moujib — 2001
• Serum measurement of osteoprotegerin--clinical relevance and potential applications.John C. Eidson, Stan Woods — 2001
• Features of mono‐ and multinucleated bone resorbing cells of the zebrafish Danio rerio and their contribution to skeletal development, remodeling, and growthGuglielmo Malizia — 2001
• Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis.Vladimir I. Arnold — 2003
• Identification of RANKL in Osteolytic Lesions of the Facial Skeleton正知 堀江 — 2004
• Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies.Allen Anandarajah, Edward M. Schwarz — 2009
• How we got attached to Actinobacillus actinomycetemcomitans: A model for infectious diseases.G. I. Gakh, Yu.V. Kulish — 2006
• High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes.Daniel Gil Pérez, Amparo Vilches, Marcela Hernández — 2006
• Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.Giorgos Bamias, Spyros I. Siakavellas, Kimon Stamatelopoulos — 2008
• Innate Immune-Like Function of Osteogenic Cells and Their Effects on Inflammatory OsteolysisHeon Goo Lee — 2014
• T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1γ.泰章 佐藤 — 2011
• T cells as key players for bone destruction in gouty arthritis?Gabriela Reyes González, Johanna Lachmann — 2011
• Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in ratsJianping Zhou, Gang Feng, Z W — 2011
• Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorptionFabrice Huet — 2015
• Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice.S. Stournas, E. Lois, P. Polyssis — 2018
• Immunoporosis: Immunology of Osteoporosis—Role of T Cells正行 西河 — 2018
• Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKL.Gunther Spohn, Martin F. Bachmann — 2007
• RANKL inhibition: from mice to men (and women).Marina Stolina, Paul J. Kostenuik, William C. Dougall — 2007
• TRANCE/RANKL in bone erosion in arthritisRiako Masuda — 2002

Related papers

• [Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages].Xiong‐Wen Zhou, Yingchun Liu, Xin-chun Jian — 2011
• [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention].Ningning Zhao, Jiuxiang Lin, Zhibin Chen — 2012
• Different expressing levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand from osteoblasts of young, adult and aged miceHuo Jian-zhon — 2005
• Aging effect of osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in human periodontal ligament cells under continuous static pressure.Jie Wu, Zhanqin Cui, Han Yu — 2022
• EFFECTS OF 1α,25(OH)_2D_3 ON THE EXPRESSION OF RECEPTOR ACTIVATOR OF NF-КB LIGAND AND OSTEOPROTEGERIN IN RAT OSTEOBLASTS IN VITROLiu Zong-ping — 2010
• Differential Expression of RANKL and Osteoprotegerin in Gingival Crevicular Fluid of Patients with PeriodontitisMakio Mogi, Jun-ichi Otogoto, Norio Ota — 2004
• Influence of high + Gz environment on receptor activator of nuclear factor κB ligand and osteoprotegerin mRNA expression in the peri-implant bone tissueXiaoru Zhu, Tianzheng Deng, Jianliang Pang — 2018
• Effects of Serum Containing Gukang on Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in the Cell Co-culture SystemZetian Li — 2012
• [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period].Wenjuan Zhou, Zhonghao Liu, Peng-Jie Hao — 2012